Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03840109 · ClinicalTrials.gov registry record
Emotional Support Messages Following a Cancer Diagnosis
A clinical trial, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- 417
- Enrollment target
NCT03840109 is a clinical trial that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 417 participants.
The verdict
NCT03840109 has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- 417 participants
- Enrollment target
Study Summary
Cancer patients will be randomly shown one of 18 emotional support messages created by the research team that differ based on how much of the message consists of positive statements and how much consists of negative statements. The messages with negative statements also differ based on whether the negative statements occur at the start or end of the message. After viewing the message, participants have the opportunity to rate the effectiveness of the message, to what extent the message made them feel better, and to what extent the message affects how they view the message provider as a useful source of emotional support.
Interventions
- BEHAVIORAL Questionnaire 1a
- BEHAVIORAL Questionnaire 1b
- BEHAVIORAL Questionnaire 2a
- BEHAVIORAL Questionnaire 2b
- BEHAVIORAL Questionnaire 3a
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 417 participants |
| Start Date | 2019-01-30 |
| Est. Completion | 2020-11-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03840109
The ClinicalTrials.gov registry entry for NCT03840109 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 417 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Questionnaire 1a is the first listed.
NCT03840109 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03840109 about?
NCT03840109 is a clinical study titled "Emotional Support Messages Following a Cancer Diagnosis". Cancer patients will be randomly shown one of 18 emotional support messages created by the research team that differ based on how much of the message consists of positive statements and how much consists of negative statements. The messages with negative statements also differ based on whether the n...
What is the current status of trial NCT03840109?
This trial is currently completed. The enrollment target is 417 participants. The study started on 2019-01-30. Estimated completion is 2020-11-24.
What interventions are being tested in trial NCT03840109?
The interventions under investigation include: Questionnaire 1a (BEHAVIORAL), Questionnaire 1b (BEHAVIORAL), Questionnaire 2a (BEHAVIORAL), Questionnaire 2b (BEHAVIORAL), Questionnaire 3a (BEHAVIORAL).
Who is sponsoring clinical trial NCT03840109?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.